Ryan White, a young boy from Kokomo, became a national symbol in the fight against AIDS-related discrimination after being ...

Qfitlia (fitusiran) is the first therapy for both hemophilia A or B, with or without inhibitors, available in the United States.

The gene therapy BBM-H901 (dalnacogene ponparvovec) has been approved in China for adults with moderate to severe hemophilia ...

Despite the challenges, including what CSL CEO Paul McKenzie has described as a fragmented U.S. healthcare system, the blood product specialist remains hopeful that Hemgenix is here to stay. “I hope ...

New treatments for Prader-Willi Syndrome and hemophilia; FDA fast tracks a chlamydia vaccine candidate; over-the-counter test cleared for identifying chlamydia, gonorrhea and trichomoniasis.

Columnist Jennifer Lynne shares her takeaways from the NOW Conference, which brought together people with VWD and other bleeding disorders.

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Authorities in Kathmandu are in a fix regarding what to do about four Bhutanese nationals who have been left stranded in Nepal after being disowned by Thimphu. The four refugees had earlier left for ...

The Border Guard Bangladesh (BGB) has written to the Border Security Force (BSF) requesting a flag meeting for the release of ...

Thinking of applying for Social Security Disability Insurance? Here's how to check your eligibility and apply.

H901, has been officially approved by the National Medical Products Administration for the treatment of adult patients with moderate to severe hemophilia B.